Ginkgo Bioworks Holdings, Inc. (DNA) NYSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Ginkgo Bioworks Holdings, Inc.
Address
27 Drydock Avenue
Boston, MA 02210
United States of America (the)
Phone
877 422 5362
Sector
Healthcare
Industry
Biotechnology
Employees
834
First IPO Date
April 19, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Jason Kelly | Co-Founder, Co-COO, CEO & Director | 255,000 | 1981 |
| Reshma Shetty | Co-Founder, President & Director | 255,000 | 1981 |
| Steven Coen | Chief Financial Officer | 438,692 | 1966 |
| Samantha Sutton | Head of People | 0 | N/A |
| Jennifer Wipf | Co-Chief Operating Officer | 0 | N/A |
| Karen Tepichin | General Counsel & Secretary | 0 | N/A |
| Brian O'sullivan | Head of Commercial | 0 | N/A |
| Daniel Marshall | Senior Manager of Communications & Ownership | 0 | N/A |
| Bartholomew Canton | Co-Founder & CTO | 0 | N/A |
| Austin Che | Co-Founder & Head of Strategy | 0 | N/A |
| Thomas Knight Jr. | Founder | 0 | N/A |
Description
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.
